D1ckDAO

Men's Health

When men lose their edge, they lose more than performance — they lose themselves. D1CK DAO is fighting back with real science. Over 300 million men worldwide suffer from erectile dysfunction, one in three experience premature ejaculation, and mean Testosterone level have dropped more than 20% since 2000s — yet real solutions remain rare, and stigma remains high. Our vision is to build a decentralized community where scientists and men work together to solve the real, often-ignored problems men face, not just the profitable ones. We believe men deserve more than quick fixes. They deserve real solutions, real science, and a future they can stand proud in — both inside and out.

Learn more:

Market Hypothesis

300M men

Erectile dysfunction (ED) affects approximately 300 million men worldwide

6B projected market value

Men’s sexual health supplement market projected to exceed $6 billion by 2030

<1% of NIH funding

Direct funding for male sexual health research represents less than 1% of NIH’s overall annual research budget.

There is no dedicated Office for Men’s Health at NIH. No targeted funding. Yet over 300 million men continue to struggle in silence. It’s time to address what the system has long ignored.


Men’s sexual health is a critical yet deeply underserved field. Over 300 million men globally suffer from erectile dysfunction, one in three experience premature ejaculation, and up to 40% face low testosterone, issues that impact not only physical h...

Research Focus Areas
Restoring Erectile Dysfunction through Science

Restoring Erectile Dysfunction through Science

We are developing a next-generation, multi-targeted supplement formulation to enhance erectile function, optimize hormonal balance, and promote holistic male sexual wellness. Built on clinically validated bioactive compounds, this project aims to shift the standard from superficial fixes to science-backed, measurable outcomes.


TRIAXIS: Revolutionizing Testosterone Delivery for Optimal Outcomes

TRIAXIS: Revolutionizing Testosterone Delivery for Optimal Outcomes

This trial pioneers a comprehensive evaluation of testosterone delivery methods — oral, transdermal (gel), and hybrid systems — assessing their bioavailability, clinical efficacy, patient adherence, and safety. Today, most testosterone replacement therapies rely on injectable forms, which are often painful, invasive, and associated with significant side effects and poor long-term compliance. TRIAXIS seeks to define safer, more effective, and patient-friendly alternatives to restore hormonal health with precision and sustainability.


Enhancing Cognitive Vitality Through Testosterone Optimization

Enhancing Cognitive Vitality Through Testosterone Optimization

Exploring the critical connection between hormonal support and cognitive vitality. By clinically evaluating a natural testosterone-booster’s impact on memory, executive function, mood, and stress resilience, this trial aims to establish a new frontier where enhancing hormonal health translates into measurable cognitive performance.


Team & Community
Jirawee Jantaranukul

Jirawee Jantaranukul

M.D., Board-certified Urologic surgeon

board-certified urologist and founder of Mediprime Clinic, specializes in men’s health, erectile dysfunction, and hormonal optimization. With extensive...

Taweechai Prasertcharoensuk

Taweechai Prasertcharoensuk

M.D., Board-certified Cardiothoracic surgeon

Board-certified cardiothoracic surgeon and CEO of StanX Group, pioneering the use of AI to transform men’s health. Combines...

Sun

Sun

M.D.

Medical doctor and Web3 strategist approaching half a decade of experience across blockchain research, analysis and advisory. Bridging...

Fluffy

Fluffy

BA in Finance

Former Product Marketing Associate at Nansen and Co-founder of Ape Board, now leading investment initiatives at Xplor Ventures....

Pailin Goseyarakwong

Pailin Goseyarakwong

M.D., MBA (University of North Carolina)

Medical doctor and Business Development Director at GAS Studio Co., Ltd., with prior experience as Manager and Senior...

Voraphum Prayoonsuk

Voraphum Prayoonsuk

M.Sc. (University of Strathclyde), PGDip Informatics and Machine Learning (University of Edinburgh)

Full-stack developer and DevOps specialist with deep expertise in AI integration, and blockchain infrastructure. Passionate about bridging machine...

Mook

Mook

Mergers & Acquisitions (M&A) Specialist, IPO Advisory Expert

Crypto and venture investor with a strong background in M&A and IPO advisory. Specializing in navigating both decentralized...

@D1ckDAO on 𝕏

Discord community

Project Roadmap
Q3 2025
Launch D1ckDAO : DAO setup, core team formation, community building, marketing, and brand identity.
Q4 2025
Launch our first IP token, science backed supplement for Erectile Dysfunciton and hormonal balance
Q4 2025
Initiate a 150-participant study for our first IPT using standardized measures - EHS (Erection Hardness Score), qADAM, and biomarker analysis
Q1 2026
Launch Dr. D1CK – DeSci AI agent for MSH advice, data, and hypothesis generation
Q2 2026
We reclaim what was taken. Launch the second IP token that makes restoration safer, more effective, and less painful
Value Capture Model

We're the first BioDAO turning real-world profits into $D1CK buybacks — because ownership should grow with impact....

Value Capture Model Diagram
Recommended Reads
NIH Funding of Men's and Women's Health

by James L. Nuzzo

NIH Funding of Men's and Women's Health


Erectile Dysfunction (ED)

NIH

Erectile Dysfunction (ED)


Testosterone and Aging: Clinical Research Directions

NIH

Testosterone and Aging: Clinical Research Directions